Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice-Reference-Cited by-同舟云学术

Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice

Published:2014-01 Issue:1 Volume:146 Page:210-221.e13
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Hanson Miranda L.,Hixon Julie A.,Li Wenqing,Felber Barbara K.,Anver Miriam R.,Stewart C. Andrew,Janelsins Brian M.,Datta Sandip K.,Shen Wei,McLean Mairi H.,Durum Scott K.

Funder

National Cancer Institute

Eli and Edythe Broad Foundation

National Institutes of Health

Crohn's and Colitis Foundation of America

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference53 articles.

1. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences;Loftus;Gastroenterology,2004

2. The risk of colorectal cancer in ulcerative colitis: a meta-analysis;Eaden;Gut,2001

3. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases;Packey;J Intern Med,2008

4. Unravelling the pathogenesis of inflammatory bowel disease;Xavier;Nature,2007

5. Interleukin-10-deficient mice develop chronic enterocolitis;Kuhn;Cell,1993

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically engineered bacteria as inflammatory bowel disease therapeutics;Engineering Microbiology;2024-12

2. Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy;Journal of Nanobiotechnology;2024-08-24

3. Potential of using an engineered indole lactic acid producing Escherichia coli Nissle 1917 in a murine model of colitis;Scientific Reports;2024-07-30

4. Bioinspired Cellular Membrane Vesicles Derived from Bacterial and Erythrocyte Ghosts: Development and Applications as a Smart Drug Delivery System;Nano LIFE;2024-07-26

5. Engineering bacterial warriors: harnessing microbes to modulate animal physiology;Current Opinion in Biotechnology;2024-06